Actively Recruiting
CTFFR and Prediction of Non-Significant CAD Lesions
Led by Shiraz University of Medical Sciences · Updated on 2025-05-21
250
Participants Needed
1
Research Sites
139 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
In this prospective cohort study, 250 patients with suspected or known CAD and at least one intermediate coronary lesion (50-70% stenosis) who had a NiFFR value greater than 0.80 underwent coronary computed tomography angiography (CCTA) with NiFFR assessment. Patients were followed for one year to monitor for MACE
CONDITIONS
Official Title
CTFFR and Prediction of Non-Significant CAD Lesions
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with at least one intermediate coronary lesion (50-70% narrowing) on CT angiography
- Patients who underwent fractional flow reserve (FFR) testing
- Age between 20 and 80 years
You will not qualify if you...
- History of coronary artery bypass graft surgery (CABG)
- Previous percutaneous coronary intervention (PCI) in the target vessel
- Severe kidney impairment with eGFR less than 30 mL/min/1.73 m²
- Allergy to contrast dye used in imaging
- Poor image quality preventing proper CT angiography or CT-FFR analysis
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Professor Kojuri Cardiology Clinic
Shiraz, Fars, Iran, 55318
Actively Recruiting
Research Team
J
javad UOM kojuri
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
DIAGNOSTIC
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here